A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis
Clinical trial NCT05983068 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05983068
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2027-04-29
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.